AUTHOR=Zhuang Zhaomeng , Huang Chen , Zhang Yiguang , Lv Bin 

TITLE=Effects of Massa Medicata Fermentata on the intestinal pathogenic flagella bacteria and visceral hypersensitivity in rats with irritable bowel syndrome

JOURNAL=Frontiers in Physiology

VOLUME=Volume 13 - 2022

YEAR=2022

URL=https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.1039804

DOI=10.3389/fphys.2022.1039804

ISSN=1664-042X

ABSTRACT=<p><bold>Objective:</bold> To investigate the effect of Massa Medicata Fermentata (MMF) on the changes of pathogenic flagellar bacteria and visceral hypersensitivity in rats with diarrhea irritable bowel syndrome (IBS-D).</p><p><bold>Methods:</bold> Thirty adult SD rats were randomly divided into normal control group (<italic>n</italic> = 10), model control group (<italic>n</italic> = 10), and MMF group (<italic>n</italic> = 10). Acetic acid enema combined with restraint stress was used to build the IBS-D visceral hypersensitivity model; Abdominal withdrawal reflex (AWR) test was used to assess the visceral sensitivity of rats; 16SrRNA sequencing was used to analyze the changes of intestinal bacteria in each group, and the content of pathogenic flagellated bacteria were quantitatively counted; The content of flagellin in colonic mucosa was detected by ELISA; TLR5 protein in colonic mucosa of rats was detected by Western Blot.</p><p><bold>Results:</bold> After IBS-D modeling, the visceral sensitivity of rats was significantly higher in the model control group than that in the normal control group (<italic>p</italic> = 0.0061), while it was significantly decreased in MMF group compared with the model control group (<italic>p</italic> = 0.0217), but without significant difference compared with the normal control group (<italic>p</italic> = 0.6851). The number of fecal Bifidobacterium and <italic>Lactobacillus</italic> in the model group were significantly decreased compared with the normal control group (<italic>p</italic> &lt; 0.0001); While they were significantly increased in the MMF group compared with the model control group and normal control group (<italic>p</italic> = 0.009; <italic>p</italic> &lt; 0.0001). The amount of fecal pathogenic flagellated bacteria in the model group was significantly increased compared with the normal control group (<italic>p</italic> = 0.001); However it was significantly reduced in MMF group compared with the model group (<italic>p</italic> = 0.026), which has no statistically difference with the normal control group (<italic>p</italic> = 0.6486). The content of flagellin in colonic mucosa was significantly increased in the model group when compared with the normal control group (<italic>p</italic> &lt; 0.0001), and it was decreased in MMF group compared with the normal control group (<italic>p</italic> &lt; 0.0001), but there was no statistical difference with the normal control group (<italic>p</italic> = 0.6545). The expression level of TLR5 protein in colonic mucosa of rat was significantly increased in model control group compared with the normal control group (<italic>p</italic> = 0.0034), However, it was significantly decreased in MMF group compared with normal control group (<italic>p</italic> = 0.0019), but it was no statistical difference with the normal control group (<italic>p</italic> = 0.7519).</p><p><bold>Conclusion:</bold> MMF can reduce visceral hypersensitivity by decreasing the content of pathogenic flagellated bacteria and their flagellin and inhibiting its specific receptor TLR5 protein expression in colonic mucosa in IBS-D rats.</p>